Uroplasty, Inc. ( Amex UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
The newly introduced low-profile MRN-420 needle is designed to be compatible with most adult cystoscopes, instruments used to visually examine the bladder, and to perform urologic procedures. In response to customer suggestions, this needle design project was undertaken in an ongoing effort to improve procedure ease and to allow surgeons to use their cystoscope of choice. The enhanced needle flexibility provides easier handling while the smaller needle tip helps to control the precise flow and amount of product injected.